serine has been researched along with Carcinoma, Non-Small Cell Lung in 32 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-35 mg/m2) in combination with docetaxel (60 or 75 mg/m2) and cisplatin (75 mg/m2), agents were administered 24 h apart every 3 weeks to Japanese patients with advanced solid tumors." | 2.87 | Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors. ( Ecstein-Fraisse, E; Hida, T; Horiike, A; Horio, Y; Nishio, M; Satouchi, M; Sunaga, Y, 2018) |
| "Irinotecan has also displayed efficacy in clinical trials of NSCLC." | 1.42 | Topoisomerase-I PS506 as a Dual Function Cancer Biomarker. ( Gjerset, RA; Zhao, M, 2015) |
| "Our results define a role for PCK2 in cancer cell metabolic reprogramming that promotes glucose-independent cell growth and metabolic stress resistance in human tumors." | 1.42 | Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. ( Artyomov, MN; Avizonis, D; Blagih, J; Bridon, G; Choinière, L; Coelho, PP; Elder, DJ; Flynn, BR; Gingras, MC; Griss, T; Jones, RG; Loginicheva, E; Ntimbane, T; Pause, A; Raissi, TC; Samborska, B; Sergushichev, A; Tavaré, JM; Thomas, EC; Vincent, EE, 2015) |
| "In addition, LY2603618-treated lung cancer cells transitioned from LC3-I to LC3-II, a hallmark of autophagy." | 1.40 | The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells. ( Cui, YJ; Fei, HR; Li, ZM; Sun, BL; Sun, YK; Wang, FZ; Wang, XY; Yang, XY; Zhang, JG, 2014) |
| "TICs from primary NSCLC tumors express high levels of the oncogenic stem cell factor LIN28B and GLDC, which are both required for TIC growth and tumorigenesis." | 1.38 | Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. ( Ahmed, DA; Ang, HS; Bhakoo, KK; Jayapal, SR; Kaldis, P; Lim, B; Lim, EH; Ma, S; Mitchell, W; Nga, ME; Nichane, M; Noghabi, MS; Pang, YH; Rai, A; Robson, P; Shyh-Chang, N; Sing, WP; Soh, BS; Soo, RA; Sun, LL; Swarup, S; Tai, BC; Tam, J; Tan, C; Thirugananam, A; Umashankar, S; Yang, H; Yu, Q; Zhang, WC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 17 (53.13) | 24.3611 |
| 2020's | 8 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P | 1 |
| Qin, Z | 1 |
| Sun, X | 1 |
| Yang, J | 1 |
| Lv, J | 1 |
| Diao, M | 1 |
| Li, L | 2 |
| Li, P | 1 |
| Ma, X | 1 |
| Zeng, S | 2 |
| Peng, Y | 2 |
| Zhang, G | 2 |
| Du, W | 1 |
| Wang, H | 1 |
| Zhao, Y | 2 |
| Huang, Z | 1 |
| Valencia, K | 1 |
| Echepare, M | 1 |
| Teijeira, Á | 1 |
| Pasquier, A | 1 |
| Bértolo, C | 1 |
| Sainz, C | 1 |
| Tamayo, I | 1 |
| Picabea, B | 1 |
| Bosco, G | 1 |
| Thomas, R | 1 |
| Agorreta, J | 1 |
| López-Picazo, JM | 1 |
| Frigola, J | 1 |
| Amat, R | 1 |
| Calvo, A | 1 |
| Felip, E | 1 |
| Melero, I | 1 |
| Montuenga, LM | 1 |
| Li, D | 1 |
| Zhang, X | 1 |
| Ding, Z | 1 |
| Ai, R | 1 |
| Shi, L | 1 |
| Wang, Z | 1 |
| He, Q | 1 |
| Dong, Y | 1 |
| Zhu, Y | 1 |
| Ouyang, W | 1 |
| He, Y | 2 |
| Grenda, A | 1 |
| Krawczyk, P | 1 |
| Targowska-Duda, KM | 1 |
| Kieszko, R | 1 |
| Paśnik, I | 1 |
| Milanowski, J | 1 |
| Volz, C | 1 |
| Breid, S | 1 |
| Selenz, C | 1 |
| Zaplatina, A | 1 |
| Golfmann, K | 1 |
| Meder, L | 1 |
| Dietlein, F | 1 |
| Borchmann, S | 1 |
| Chatterjee, S | 1 |
| Siobal, M | 1 |
| Schöttle, J | 1 |
| Florin, A | 1 |
| Koker, M | 1 |
| Nill, M | 1 |
| Ozretić, L | 1 |
| Uhlenbrock, N | 1 |
| Smith, S | 1 |
| Büttner, R | 1 |
| Miao, H | 1 |
| Wang, B | 1 |
| Reinhardt, HC | 1 |
| Rauh, D | 1 |
| Hallek, M | 1 |
| Acker-Palmer, A | 1 |
| Heukamp, LC | 1 |
| Ullrich, RT | 1 |
| Krassikova, L | 1 |
| Zhang, B | 1 |
| Nagarajan, D | 1 |
| Queiroz, AL | 1 |
| Kacal, M | 1 |
| Samakidis, E | 1 |
| Vakifahmetoglu-Norberg, H | 1 |
| Norberg, E | 1 |
| Nishio, M | 1 |
| Satouchi, M | 1 |
| Horiike, A | 1 |
| Horio, Y | 1 |
| Sunaga, Y | 1 |
| Ecstein-Fraisse, E | 1 |
| Hida, T | 1 |
| Mu, Y | 1 |
| Zhou, Y | 2 |
| Wang, Y | 2 |
| Li, W | 1 |
| Zhou, L | 1 |
| Lu, X | 2 |
| Gao, P | 1 |
| Gao, M | 1 |
| Wang, Q | 1 |
| Xu, G | 1 |
| Shi, S | 1 |
| Zhang, J | 1 |
| Liu, M | 1 |
| Dong, H | 1 |
| Li, N | 1 |
| von Pawel, J | 1 |
| Gorbounova, V | 1 |
| Reck, M | 1 |
| Kowalski, DM | 1 |
| Allard, A | 1 |
| Chadjaa, M | 1 |
| Rey, A | 1 |
| Bennouna, J | 1 |
| Grossi, F | 1 |
| Song, L | 1 |
| Smith, MA | 1 |
| Doshi, P | 1 |
| Sasser, K | 1 |
| Fulp, W | 1 |
| Altiok, S | 1 |
| Haura, EB | 1 |
| Wang, FZ | 1 |
| Fei, HR | 1 |
| Cui, YJ | 1 |
| Sun, YK | 1 |
| Li, ZM | 1 |
| Wang, XY | 1 |
| Yang, XY | 1 |
| Zhang, JG | 1 |
| Sun, BL | 1 |
| Zajkowicz, A | 1 |
| Butkiewicz, D | 1 |
| Drosik, A | 1 |
| Giglok, M | 1 |
| Suwiński, R | 1 |
| Rusin, M | 1 |
| Yamada, N | 1 |
| Tanaka, T | 2 |
| Hori, T | 1 |
| Yokoyama, S | 1 |
| Hayakawa, Y | 1 |
| Yano, S | 1 |
| Fukuoka, J | 1 |
| Koizumi, K | 1 |
| Saiki, I | 1 |
| Sakurai, H | 1 |
| Zhao, M | 1 |
| Gjerset, RA | 2 |
| Vincent, EE | 2 |
| Sergushichev, A | 1 |
| Griss, T | 1 |
| Gingras, MC | 1 |
| Samborska, B | 1 |
| Ntimbane, T | 1 |
| Coelho, PP | 1 |
| Blagih, J | 1 |
| Raissi, TC | 1 |
| Choinière, L | 1 |
| Bridon, G | 1 |
| Loginicheva, E | 1 |
| Flynn, BR | 1 |
| Thomas, EC | 2 |
| Tavaré, JM | 2 |
| Avizonis, D | 1 |
| Pause, A | 1 |
| Elder, DJ | 2 |
| Artyomov, MN | 1 |
| Jones, RG | 1 |
| DeNicola, GM | 1 |
| Chen, PH | 1 |
| Mullarky, E | 1 |
| Sudderth, JA | 1 |
| Hu, Z | 1 |
| Wu, D | 1 |
| Tang, H | 1 |
| Xie, Y | 1 |
| Asara, JM | 1 |
| Huffman, KE | 1 |
| Wistuba, II | 1 |
| Minna, JD | 1 |
| DeBerardinis, RJ | 1 |
| Cantley, LC | 1 |
| Riscal, R | 1 |
| Schrepfer, E | 1 |
| Arena, G | 1 |
| Cissé, MY | 1 |
| Bellvert, F | 1 |
| Heuillet, M | 1 |
| Rambow, F | 1 |
| Bonneil, E | 1 |
| Sabourdy, F | 1 |
| Vincent, C | 1 |
| Ait-Arsa, I | 1 |
| Levade, T | 1 |
| Thibaut, P | 1 |
| Marine, JC | 1 |
| Portais, JC | 1 |
| Sarry, JE | 1 |
| Le Cam, L | 1 |
| Linares, LK | 1 |
| Kreager, DA | 1 |
| Ragan, DT | 1 |
| Nguyen, H | 1 |
| Staff, J | 1 |
| Bartosh, TJ | 1 |
| Ylostalo, JH | 1 |
| Dutta, NK | 1 |
| He, R | 1 |
| Pinn, ML | 1 |
| Burrows, F | 1 |
| Zhang, ZY | 1 |
| Karakousis, PC | 1 |
| Jin, YJ | 1 |
| Wang, S | 1 |
| Cho, J | 1 |
| Selim, MA | 1 |
| Wright, T | 1 |
| Mosialos, G | 1 |
| Zhang, JY | 1 |
| Roy, S | 1 |
| Karmakar, T | 1 |
| Nagappa, LK | 1 |
| Prahlada Rao, VS | 1 |
| Balasubramanian, S | 1 |
| Balaram, H | 1 |
| Mazuquin, BF | 1 |
| Dela Bela, LF | 1 |
| Pelegrinelli, AR | 1 |
| Dias, JM | 1 |
| Carregaro, RL | 1 |
| Moura, FA | 1 |
| Selfe, J | 1 |
| Richards, J | 1 |
| Brown, LE | 1 |
| Cardoso, JR | 1 |
| Naeem, MA | 1 |
| Armutlulu, A | 1 |
| Broda, M | 1 |
| Lebedev, D | 1 |
| Müller, CR | 1 |
| Jin, X | 1 |
| Liang, N | 1 |
| Wang, M | 1 |
| Meng, Y | 1 |
| Jia, B | 1 |
| Shi, X | 1 |
| Li, S | 1 |
| Luo, J | 1 |
| Luo, Y | 1 |
| Cui, Q | 1 |
| Zheng, K | 1 |
| Liu, Z | 1 |
| Shi, J | 1 |
| Li, F | 1 |
| Wang, F | 1 |
| Zhu, Z | 1 |
| Gallo, S | 1 |
| Woolfrey, AE | 1 |
| Burroughs, LM | 1 |
| Storer, BE | 1 |
| Flowers, ME | 1 |
| Hari, P | 1 |
| Pulsipher, MA | 1 |
| Heimfeld, S | 1 |
| Kiem, HP | 1 |
| Sandmaier, BM | 1 |
| Storb, R | 1 |
| Cho, KJ | 1 |
| Casteel, DE | 1 |
| Prakash, P | 1 |
| Tan, L | 1 |
| van der Hoeven, D | 1 |
| Salim, AA | 1 |
| Kim, C | 1 |
| Capon, RJ | 1 |
| Lacey, E | 1 |
| Cunha, SR | 1 |
| Gorfe, AA | 1 |
| Hancock, JF | 1 |
| Ko, E | 1 |
| Kim, Y | 1 |
| Lee, BB | 1 |
| Han, J | 1 |
| Song, SY | 1 |
| Shim, YM | 1 |
| Park, J | 1 |
| Kim, DH | 1 |
| Phillips, L | 1 |
| Morgan, C | 1 |
| Pawade, J | 1 |
| Sohail, M | 1 |
| May, MT | 1 |
| Hetzel, MR | 1 |
| Zhang, WC | 1 |
| Shyh-Chang, N | 1 |
| Yang, H | 1 |
| Rai, A | 1 |
| Umashankar, S | 1 |
| Ma, S | 1 |
| Soh, BS | 1 |
| Sun, LL | 1 |
| Tai, BC | 1 |
| Nga, ME | 1 |
| Bhakoo, KK | 1 |
| Jayapal, SR | 1 |
| Nichane, M | 1 |
| Yu, Q | 1 |
| Ahmed, DA | 1 |
| Tan, C | 1 |
| Sing, WP | 1 |
| Tam, J | 1 |
| Thirugananam, A | 1 |
| Noghabi, MS | 1 |
| Pang, YH | 1 |
| Ang, HS | 1 |
| Mitchell, W | 1 |
| Robson, P | 1 |
| Kaldis, P | 1 |
| Soo, RA | 1 |
| Swarup, S | 1 |
| Lim, EH | 1 |
| Lim, B | 1 |
| Rettig, M | 1 |
| Trinidad, K | 1 |
| Pezeshkpour, G | 1 |
| Frost, P | 1 |
| Sharma, S | 1 |
| Moatamed, F | 1 |
| Tamanoi, F | 1 |
| Mortazavi, F | 1 |
| Yap, DB | 1 |
| Hsieh, JK | 1 |
| Zhong, S | 1 |
| Heath, V | 1 |
| Gusterson, B | 1 |
| Crook, T | 1 |
| Ichwan, SJ | 1 |
| Yamada, S | 1 |
| Sumrejkanchanakij, P | 1 |
| Ibrahim-Auerkari, E | 1 |
| Eto, K | 1 |
| Ikeda, MA | 1 |
| Scaglioni, PP | 1 |
| Yung, TM | 1 |
| Cai, LF | 1 |
| Erdjument-Bromage, H | 1 |
| Kaufman, AJ | 1 |
| Singh, B | 1 |
| Teruya-Feldstein, J | 1 |
| Tempst, P | 1 |
| Pandolfi, PP | 1 |
| Yuan, BZ | 1 |
| Jefferson, AM | 1 |
| Millecchia, L | 1 |
| Popescu, NC | 1 |
| Reynolds, SH | 1 |
| Bandyopadhyay, K | 1 |
| Lee, C | 1 |
| Haghighi, A | 1 |
| Banères, JL | 1 |
| Parello, J | 1 |
| Oda, K | 1 |
| Arakawa, H | 1 |
| Matsuda, K | 1 |
| Tanikawa, C | 1 |
| Mori, T | 1 |
| Nishimori, H | 1 |
| Tamai, K | 1 |
| Tokino, T | 1 |
| Nakamura, Y | 1 |
| Taya, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label, Dose-escalation, Safety and Pharmacokinetics Phase I Study of Ombrabulin in Combination With Docetaxel and Cisplatin Every 3 Weeks in Patients With Advanced Solid Tumors[NCT01095302] | Phase 1 | 11 participants (Actual) | Interventional | 2010-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for serine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Extracellular Signal-Regulated MAP K | 2023 |
2 trials available for serine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Ca | 2018 |
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compoun | 2014 |
29 other studies available for serine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Expression and Clinical Significance of lncRNA OSER1-AS1 in Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Chondroitin Sulfates; Gene Expression Regulation, Neoplastic; Humans | 2022 |
Therapeutic restoring p53 function with small molecule for oncogene-driven non-small cell lung cancer by targeting serine 392 phosphorylation.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Humans; Lung Neoplasms; | 2022 |
Small-molecule MX-C2/3 suppresses non-small cell lung cancer progression via p53 activation.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neopla | 2022 |
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Receptor-Interacting Protein Serine-Threonin | 2022 |
Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer.
Topics: Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Gene Expression Re | 2022 |
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC.
Topics: Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; | 2020 |
The deubiquitinase JOSD2 is a positive regulator of glucose metabolism.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Endopeptidases; Femal | 2021 |
Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
Topics: Adult; Aged; Amino Acids; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; C | 2019 |
Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cyclic AMP-Dependent | 2019 |
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chem | 2014 |
The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.
Topics: Antineoplastic Agents; Antirheumatic Agents; Autophagy; Carcinoma, Non-Small-Cell Lung; Caspases; Ce | 2014 |
Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Codon, Nonsense; DNA Damage; DNA, Ne | 2015 |
Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Catalysis; Cell Line, Tumor; Cell Movement; Cytoki | 2015 |
Topoisomerase-I PS506 as a Dual Function Cancer Biomarker.
Topics: Amino Acid Sequence; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Camptothecin; Carcinoma, | 2015 |
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth.
Topics: Adaptation, Physiological; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Prolifera | 2015 |
NRF2 regulates serine biosynthesis in non-small cell lung cancer.
Topics: Adenocarcinoma; Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Non-Small-Cell | 2015 |
Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
Topics: Activating Transcription Factor 4; Animals; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell P | 2016 |
Topics: Adolescent; Adult; Age Factors; Aged; Amino Acid Substitution; Anemia, Aplastic; Athletes; Athletic | 2016 |
AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.
Topics: AMP-Activated Protein Kinases; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; | 2016 |
Relationship of phospho-pRb (Ser-807/811) level to exposure to tobacco smoke in primary non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; DNA Methylation; Female; Humans; Immunohistochemistry; Lung Neoplasm | 2009 |
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer.
Topics: Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Enzyme Activation; Female; Humans; Lung Neoplasms | 2011 |
Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis.
Topics: Amino Acid Sequence; Antigens, CD; Carcinoma, Non-Small-Cell Lung; Cell Adhesion Molecules, Neuronal | 2012 |
PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Catenins; Cell Line, Tumor; Cell Movement; Delta Catenin; Gene Expre | 2012 |
Ser392 phosphorylation regulates the oncogenic function of mutant p53.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; | 2004 |
Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells.
Topics: Adenoviridae; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung Neop | 2006 |
A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Ca | 2006 |
Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells.
Topics: Actins; Amino Acid Sequence; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movem | 2007 |
Serine phosphorylation-dependent coregulation of topoisomerase I by the p14ARF tumor suppressor.
Topics: Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; DNA Damage; DNA Topoisomerases, Type | 2007 |
p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.
Topics: Adenocarcinoma; Animals; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoma, Non- | 2000 |